NCT02578680 2024-09-20MK-3475-189Merck Sharp & Dohme LLCPhase 3 Completed616 enrolled 19 charts 1 FDA
NCT00806819 2017-02-02Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCBoehringer IngelheimPhase 3 Completed718 enrolled 21 charts